In a mixed week for European markets, the pan-European STOXX Europe 600 Index edged higher amid dovish signals from the U.S. Federal Reserve and easing trade tensions between the U.S. and China, while major indexes such as Germany’s DAX and the UK’s FTSE 100 faced declines. In this environment, growth companies with high insider ownership often attract attention as they can indicate confidence in a company’s potential amidst fluctuating market conditions.
Name
Insider Ownership
Earnings Growth
Xbrane Biopharma (OM:XBRANE)
13%
112.0%
Pharma Mar (BME:PHM)
11.9%
44.2%
MedinCell (ENXTPA:MEDCL)
12.5%
90.4%
KebNi (OM:KEBNI B)
36.3%
74%
Elliptic Laboratories (OB:ELABS)
22.5%
97.9%
Egetis Therapeutics (OM:EGTX)
10.3%
85%
CTT Systems (OM:CTT)
17.5%
37.9%
Circus (XTRA:CA1)
24.1%
67.1%
CD Projekt (WSE:CDR)
29.7%
39.7%
Bonesupport Holding…
